|
Yale Cancer Center NCTN
|
5U10CA180826-02
|
$551,500
|
HOCHSTER, HOWARD
|
YALE UNIVERSITY
|
|
UW Comprehensive Cancer Center Support
|
3P30CA014520-41S1
|
$37,429
|
BAILEY, HOWARD
|
UNIVERSITY OF WISCONSIN-MADISON
|
|
UW Comprehensive Cancer Center Support
|
3P30CA014520-41S2
|
$125,000
|
BAILEY, HOWARD
|
UNIVERSITY OF WISCONSIN-MADISON
|
|
UW Comprehensive Cancer Center Support
|
5P30CA014520-41
|
$4,288,496
|
BAILEY, HOWARD
|
UNIVERSITY OF WISCONSIN-MADISON
|
|
UNMC Eppley Cancer Center Support Grant
|
3P30CA036727-29S1
|
$89,185
|
COWAN, KENNETH
|
UNIVERSITY OF NEBRASKA MEDICAL CENTER
|
|
UNMC Eppley Cancer Center Support Grant
|
5P30CA036727-29
|
$1,485,000
|
COWAN, KENNETH
|
UNIVERSITY OF NEBRASKA MEDICAL CENTER
|
|
University of Michigan Comprehensive Cancer Center Support Grant
|
3P30CA046592-27S1
|
$198,450
|
LAWRENCE, THEODORE
|
UNIVERSITY OF MICHIGAN
|
|
University of Michigan Comprehensive Cancer Center Support Grant
|
5P30CA046592-27
|
$6,097,616
|
LAWRENCE, THEODORE
|
UNIVERSITY OF MICHIGAN
|
|
Understanding Variation in Radioactive Iodine Use in Treatment of Thyroid Cancer
|
5K07CA154595-05
|
$167,096
|
HAYMART, MEGAN
|
UNIVERSITY OF MICHIGAN
|
|
TXNIP as a Key Regulator of Thyroid Cancer Metabolism and Aggressiveness
|
5R01CA175994-03
|
$322,403
|
HAUGEN, BRYAN
|
UNIVERSITY OF COLORADO DENVER
|
|
Two-Photon Fluorescence Lifetime Microscopy for Breast and Thyroid Cancer Margin
|
5F32CA183400-02
|
$54,194
|
GIACOMELLI, MICHAEL
|
MASSACHUSETTS INSTITUTE OF TECHNOLOGY
|
|
Trinity Field Study
|
ZIA CP010185 - 10694
|
$317,868
|
Simon, Steven
|
DCEG (NCI)
|
|
Translational Surgical Pathology
|
ZIE SC 000853
|
$171,153
|
Merino, Maria
|
CCR (NCI)
|
|
Thyroid Stem/Progenitor Cells
|
ZIA BC 005522
|
$416,092
|
Kimura, Shioko
|
CCR (NCI)
|
|
Thyroid Cancer among Chornobyl Clean-up Workers in Ukraine: Pilot Study
|
ZIA CP010133 - 10531
|
$439,378
|
Mabuchi, Kiyohiko
|
DCEG (NCI)
|
|
Therapeutic targets and novel anticancer agents for endocrine cancers
|
ZIA BC 011286
|
$689,189
|
Kebebew, Electron
|
CCR (NCI)
|
|
Theranostic nanoparticles for the treatment of RAI refractory thyroid cancer
|
5R01CA178007-03
|
$351,713
|
JIN, MOONSOO
|
WEILL MEDICAL COLL OF CORNELL UNIV
|
|
The Role of Fragile Sites in RET/PTC Rearrangement
|
2R01CA113863-06A1
|
$312,876
|
WANG, YUH-HWA
|
UNIVERSITY OF VIRGINIA
|
|
The Role of BRAF Mutation in Thyroid Cancer Invasion
|
5R01CA149738-05
|
$319,757
|
PARANGI, SAREH
|
MASSACHUSETTS GENERAL HOSPITAL
|
|
The Ohio State University and MD Anderson Cancer Center Thyroid Cancer SPORE
|
5P50CA168505-03
|
$2,184,999
|
RINGEL, MATTHEW
|
OHIO STATE UNIVERSITY
|
|
The NFkB-dependent Secretome and Invasion/Angiogenesis in Thyroid Cancer
|
5R01CA155512-05
|
$309,469
|
HAUGEN, BRYAN
|
UNIVERSITY OF COLORADO DENVER
|
|
The Chernobyl Tissue Bank - Coordinating Center
|
3U24CA082102-14S1
|
$5,617
|
THOMAS, GERALDINE
|
U OF L IMPERIAL COL OF SCI/TECHNLGY/MED
|
|
The Chernobyl Tissue Bank - Coordinating Center
|
5U24CA082102-15
|
$243,449
|
THOMAS, GERALDINE
|
U OF L IMPERIAL COL OF SCI/TECHNLGY/MED
|
|
TGIB Surgical Oncology Fellowship Program
|
ZIE BC 011542
|
$971,915
|
Schrump, David
|
CCR (NCI)
|
|
TERT Promoter Mutations in Thyroid Cancer
|
1R01CA189224-01A1
|
$362,066
|
XING, MICHAEL
|
JOHNS HOPKINS UNIVERSITY
|
|
Targeting MEK to Restore Radioiodine Efficacy for RAI-Refractory Thyroid Cancer
|
1R01CA184724-01A1
|
$526,578
|
HO, ALAN
|
SLOAN-KETTERING INST CAN RESEARCH
|
|
Targeting Focal Adhesion Kinase in Thyroid Cancer
|
5R01CA164193-04
|
$320,359
|
SCHWEPPE, REBECCA
|
UNIVERSITY OF COLORADO DENVER
|
|
Studies in the Janus Cohort
|
ZIA CP010120 - 02135
|
$134,591
|
Rothman, Nathaniel
|
DCEG (NCI)
|
|
SPORE in Thyroid Cancer
|
5P50CA172012-02
|
$2,029,832
|
FAGIN, JAMES
|
SLOAN-KETTERING INST CAN RESEARCH
|
|
Single cell analysis of intratumoral heterogeneity in parathyroid neoplasia
|
1R21CA192004-01
|
$195,180
|
KOH, JAMES
|
DUKE UNIVERSITY
|
|
Shanghai prospective cohort study of occupational exposures and cancer risk among
|
ZIA CP010123 - 02342
|
$352,817
|
Rothman, Nathaniel
|
DCEG (NCI)
|
|
Selective RET Kinase and Its Mutant Inhibitors for the Treatment of Medullary Thy
|
1R01CA197178-01A1
|
$307,773
|
LI, HONG-YU
|
UNIVERSITY OF ARIZONA
|
|
Risk factors for thyroid cancer in the NCI cohorts
|
ZIA CP010219 - 10447
|
$47,865
|
Berrington, Amy
|
DCEG (NCI)
|
|
Research Management and Support
|
RMS ES 2015
|
$348,215,937
|
Unknown, Unknown
|
National Cancer Institute
|
|
Regional Oncology Research Center
|
3P30CA006973-52S1
|
$31,250
|
NELSON, WILLIAM
|
JOHNS HOPKINS UNIVERSITY
|
|
Regional Oncology Research Center
|
3P30CA006973-52S2
|
$125,000
|
NELSON, WILLIAM
|
JOHNS HOPKINS UNIVERSITY
|
|
Regional Oncology Research Center
|
3P30CA006973-52S3
|
$185,800
|
NELSON, WILLIAM
|
JOHNS HOPKINS UNIVERSITY
|
|
Regional Oncology Research Center
|
5P30CA006973-52
|
$6,995,267
|
NELSON, WILLIAM
|
JOHNS HOPKINS UNIVERSITY
|
|
RCAN1 in Thyroid Cancer Progression
|
5R01CA152066-05
|
$330,672
|
RINGEL, MATTHEW
|
OHIO STATE UNIVERSITY
|
|
Radiation and molecular and genetic studies of thyroid cancer
|
ZIA CP010132 - 10650
|
$214,455
|
Mabuchi, Kiyohiko
|
DCEG (NCI)
|
|
Prospective study of farmers and their families (Agricultural health study)
|
ZIA CP010119 - 02020
|
$430,051
|
Alavanja, Michael
|
DCEG (NCI)
|
|
Predictive MRI metrics for tumor aggressiveness in micropapillary thyroid cancer
|
5R21CA176660-02
|
$368,728
|
DAVE, AMITA
|
SLOAN-KETTERING INST CAN RESEARCH
|
|
Preclinical Mouse Model of Thyroid Carcinogenesis
|
ZIA BC 011191
|
$521,597
|
Cheng, Sheue-yann
|
CCR (NCI)
|
|
PKA and follicular thyroid carcinogenesis: Roles of interacting pathways
|
5R01CA170249-03
|
$316,438
|
KIRSCHNER, LAWRENCE
|
OHIO STATE UNIVERSITY
|
|
PI3K-mediated metabolic alterations in the pre-neoplastic thyroid
|
5R01CA167839-03
|
$172,015
|
DI CRISTOFANO, ANTONIO
|
ALBERT EINSTEIN COLLEGE OF MEDICINE
|
|
PI3K-mediated metabolic alterations in the pre-neoplastic thyroid
|
6R01CA167839-04
|
$174,510
|
DI CRISTOFANO, ANTONIO
|
ALBERT EINSTEIN COLLEGE OF MEDICINE
|
|
PHAH and thyroid cancer
|
ZIA CP010125 - 10473
|
$41,529
|
Ward, Mary
|
DCEG (NCI)
|
|
OSU as Network Lead Academic Participating Site for the NCI NCTN
|
5U10CA180850-02
|
$1,383,057
|
GOLDBERG, RICHARD
|
OHIO STATE UNIVERSITY
|
|
Optimizing Radiosensitization in Anaplastic Thyroid Cancer with Metabolic Imaging
|
5R21CA178450-02
|
$208,800
|
LAI, STEPHEN
|
UNIVERSITY OF TX MD ANDERSON CAN CTR
|
|
Optimization of Treatment of Papillary Thyroid Cancer: A Risk-tailored Approach
|
5K07CA177900-02
|
$142,352
|
LUBITZ, CARRIE
|
MASSACHUSETTS GENERAL HOSPITAL
|
Relevant funding data is only available when one cancer type or one research topic is selected.
|